Clinical evaluation and management of myasthenia gravis.
about
Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromesEphedrine for myasthenia gravis3,4-Diaminopyridine for myasthenia gravisMyasthenia gravis: past, present, and futureThe MG Composite: A valid and reliable outcome measure for myasthenia gravis.Mechanisms of Autoantibody-Induced Pathology.Specific immunotherapy of experimental myasthenia gravis by a novel mechanism.A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis.Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population.Antigen-specific immunotherapeutic vaccine for experimental autoimmune myasthenia gravisMuscle giants: molecular scaffolds in sarcomerogenesis.Comparison of IVIg and PLEX in patients with myasthenia gravis.Gender and Ethnicity Based Differences in Clinical and Laboratory Features of Myasthenia Gravis.Ephedrine as add-on therapy for patients with myasthenia gravis: protocol for a series of randomised, placebo-controlled n-of-1 trials.Effect of Gender, Disease Duration and Treatment on Muscle Strength in Myasthenia Gravis.Complicating autoimmune diseases in myasthenia gravis: a review.Myotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse models.Myasthenia gravis: a review.Determination of the normative values of the masseter muscle by single-fiber electromyography in myasthenia gravis patients.Autoimmune channelopathies.Skeletal muscle function during exercise-fine-tuning of diverse subsystems by nitric oxideMyasthenia gravis appearing after thymectomy: a case report and review of the literature.IL-4 receptor as a bridge between the immune system and muscle in experimental myasthenia gravis I: up-regulation of muscle IL-15 by IL-4Prevalence and impact of autoimmune thyroid disease on myasthenia gravis course.Refractory myasthenia gravis - clinical profile, comorbidities and response to rituximab.Autoimmune myasthenia gravis.Treatment strategies for myasthenia gravis.Feeding and Swallowing Disorders in Pediatric Neuromuscular Diseases: An Overview.Therapeutic Plasma Exchange in Neurologic Diseases: An Experience with 91 Patients in Seven Years.Autoantibodies in neuromuscular autoimmune disorders.A standardized protocol for the perioperative management of myasthenia gravis patients. Experience with 110 patients.Cost analysis of myasthenia gravis from a large U.S. insurance database.Neuronal involvement in muscular atrophy.Life-threatening misdiagnosis of bulbar onset myasthenia gravis as a motor neuron disease: How much can one rely on exaggerated deep tendon reflexes.Overcoming challenges in the diagnosis and treatment of myasthenia gravis.Repetitive nerve stimulation cutoff values for the diagnosis of myasthenia gravis.Botulism Outbreak in a Family after Ingestion of Locally Produced Cheese.Association of myasthenia gravis and antisynthetase syndrome: a case report.Clinical features of patients with Myasthenia gravis from the Henan province, China.A middle-aged man with generalised weakness and dyspnoea.
P2860
Q24187268-B626F455-03BD-42C0-9D9B-E3BE6C23CEFFQ24201819-B8876664-AB7D-49A0-B5D8-7883D5499205Q24203777-F0FA8B5E-771C-44F5-9A29-D8B9C4C6C21DQ24678531-C0E7B9B4-E608-4D4E-9004-41F8890D71F9Q30424639-128CC3B5-8E26-4A4A-B325-FE1AF4B54577Q33740580-BD5C9F5D-58A7-46E0-8094-0C8608E3047BQ33831279-6EEBE394-CCC1-4478-9FA3-2B0E6DC504BEQ33983913-844E9E25-7EE1-4123-AB2D-CD3FD29B6E2CQ34270872-2C2C010A-4689-49B3-BBEF-39F4835CAC4BQ34755933-DAB8BA44-92E6-4DC2-BD46-CF227BF21DB4Q34793699-38886E6A-90AA-4455-BE64-A43E16AB776CQ35030406-0FA29FFE-804A-4F7B-A7F5-A30B037FEFD2Q35794114-DDC8FA47-3119-45D2-9E85-FCE7C23AE5C0Q35884892-868FE777-CF7F-4973-8037-2517E78327CEQ36163640-2DAA6BC1-DF31-4802-A665-EB219110CBBBQ36192435-8C6D957C-CC0A-4BF6-8762-D69B00F9DFB7Q36359231-C5DCC3DF-4701-4E62-A643-6E1BD91E77A8Q36410472-FFBCF6A8-165D-4A15-8FE5-2E67F4CC4FAEQ36412294-57349FC6-6BDA-4E6A-BFF1-D4E60C832994Q36577209-98EBA15C-BC7F-46F3-AFB7-54759885CD83Q36820423-9EDF2B11-3D36-4F33-BE63-AE22956AD378Q37203239-8A4D58E6-D172-48DC-A79C-47E52D81CD20Q37328196-D443918A-02C8-4940-B490-79F270A20FDEQ37339780-954E52DD-0B64-430C-8CD0-0513E601C8F1Q37344993-1EEB60CB-DA01-4CB2-9675-DCB6A0DFC9BCQ37409490-80A147E4-870C-4B9D-A538-81570C611FB6Q37483922-A055675E-FA09-4B86-B2D7-3BCDFB7A074DQ37589746-64AA31F3-052D-409B-91CC-B5925A158FECQ37725863-41145647-0908-41EC-86E1-B0DEDA3541B9Q37754738-C5A7C6AB-EEDD-49D3-B4C7-270F1D6CCC24Q37957180-20175894-30FF-4672-9E3C-DA379C1432EFQ37958826-DC19CE9E-1C33-458A-B285-756A8911998BQ38300566-B4BE5DA5-DBCC-4676-9CAB-19C81AB51826Q38388781-42BBC00F-D6AF-45D1-8CB8-37D70F2B9527Q38671442-1B7563A8-C7E8-4938-8575-CE5EDA447530Q38861799-F7C51AF7-BEC9-468D-B5FF-D102F86D15E8Q40266087-6BD73287-6D95-484F-95C6-41AA3168B55BQ40524597-6E52506C-C994-4C5E-9A9E-DFFA0A123F95Q41320746-70408036-4682-4EC3-847A-9B8A8140D0FEQ41615893-64FF48BB-D6AB-4BD6-A739-E05A3A32D0DE
P2860
Clinical evaluation and management of myasthenia gravis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Clinical evaluation and management of myasthenia gravis.
@ast
Clinical evaluation and management of myasthenia gravis.
@en
type
label
Clinical evaluation and management of myasthenia gravis.
@ast
Clinical evaluation and management of myasthenia gravis.
@en
prefLabel
Clinical evaluation and management of myasthenia gravis.
@ast
Clinical evaluation and management of myasthenia gravis.
@en
P2860
P356
P1433
P1476
Clinical evaluation and management of myasthenia gravis.
@en
P2093
John C Keesey
P2860
P304
P356
10.1002/MUS.20030
P577
2004-04-01T00:00:00Z